Stay updated on NRP104 in Children with ADHD Clinical Trial
Sign up to get notified when there's something new on the NRP104 in Children with ADHD Clinical Trial page.

Latest updates to the NRP104 in Children with ADHD Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe ClinicalTrials.gov page displays the Phase 3 study of NRP104 in children with ADHD, including its eligibility criteria, treatment arms and doses, outcomes, investigators, and publications. The previous view showed a 403 Forbidden error and an NIH transition notice.SummaryDifference44%

- Check18 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check25 days agoChange DetectedA notice was added above the error page announcing an NIH website transition and explaining that some NIH content may use “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check32 days agoChange DetectedThe footer now identifies the site as revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check39 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check60 days agoChange DetectedThe study page now displays a 403 Forbidden error view, replacing the usual study details with a standard error page and basic site chrome. The update brings in the 403 HTML content and removes several navigation and study-content elements from the previous page.SummaryDifference17%

Stay in the know with updates to NRP104 in Children with ADHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NRP104 in Children with ADHD Clinical Trial page.